Answers are grounded in this paper and cite their sources.
BACKGROUND: Premature mortality comparisons across human papillomavirus (HPV)-associated cancers may inform prevention, but converting case-based HPV fractions to years of potential life lost (YPLL) requires assumptions about HPV-specific outcomes. METHODS: We analyzed 179,568 SEER 17 tumor records diagnosed in 2000-2018 using recorded cancer-specific deaths within five years. Site-specific case fractions defined a reference YPLL75 allocation. We examined case-composition standardization, attribution fractions, HPV-status outcome differences, cutoffs of 70, 75, and 80 years, sex and race/ethnicity subgroups, and descriptive equity decomposition, using 5,000 patient-cluster bootstrap replicates. RESULTS: The unstandardized non-cervical/cervical index increased from 0.818 to 0.935. Case-age-standardized indices decreased from 0.932 to 0.830 (change, -0.102; 95% bootstrap interval, -0.165 to -0.043). Reference final-period indices were 0.781 for YPLL70 and 1.069 for YPLL80. A hypothetical decline in the oropharyngeal HPV-related/unrelated mean-YPLL ratio from 1.00 to 0.50 yielded an unstandardized change of -0.004 (-0.063 to 0.053). Reference standardized Black-White, low-high county-income, and nonmetro-large metro gaps were 185.3, 103.4, and 38.9 YPLL75 per 100 calculable records; their directions persisted across examined allocation scenarios. CONCLUSIONS: Within these SEER records, non-cervical cancers contributed substantial premature mortality. Cervical/non-cervical balance and period comparisons depended on case composition, attribution, HPV-status outcome assumptions, and the YPLL cutoff. Equity contrasts were more consistent in direction; decomposition did not identify causal pathways.
No takes yet. Share an insight, caveat, or question.
Xue et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: